AURINIA PHARMACEUTICALS INC (AUPH) Stock Analyst Earnings Estimates
NASDAQ:AUPH - Nasdaq - CA05156V1022 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 134M 193.86% | 175.513M 30.98% | 235.133M 33.97% | 263.69M 12.15% | 312.06M 18.34% | 364.6M 16.84% | 421.18M 15.52% | 424.15M 0.71% | 383.71M -9.53% | 385.72M 0.52% | 379.35M -1.65% | |
| EBITDA YoY % growth | -108.79M 38.86% | -80.044M 26.42% | 37.864M 147.30% | 99.786M 163.54% | 131.04M 31.32% | 173.76M 32.60% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -111.5M 38.30% | -91.691M 17.77% | 18.419M 120.09% | 92.454M 401.95% | 116.95M 26.50% | 147.04M 25.73% | 197.62M 34.40% | 204.1M 3.28% | 176.01M -13.76% | 184.92M 5.06% | 189.29M 2.36% | |
| Operating Margin | -83.21% | -52.24% | 7.83% | 35.06% | 37.48% | 40.33% | 46.92% | 48.12% | 45.87% | 47.94% | 49.90% | |
| EPS YoY % growth | -0.76 46.10% | -0.54 28.95% | 0.09 116.67% | 0.60 564.13% | 0.77 29.35% | 1.05 35.55% | 1.29 23.28% | 1.34 3.95% | 1.06 -21.01% | 1.11 4.49% | 1.12 1.22% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 0.15 53.00% | 0.15 1,396.03% |
| Revenue Q2Q % growth | 67.563M -0.31% | 70.635M 17.99% |
| EBITDA Q2Q % growth | 22.936M -12.89% | 26.517M -19.95% |
| EBIT Q2Q % growth | 20.275M 72.58% | 19.939M 45.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.16 1,500.00% | 0.15 | 0.01 | 6.95% |
| Q1 2025 Q2Q % growth | 0.16 633.33% | 0.10 | 0.06 | 56.86% |
| Q4 2024 Q2Q % growth | 0.01 105.26% | -0.02 | 0.03 | 161.27% |
| Q3 2024 Q2Q % growth | 0.10 211.11% | 0.02 | 0.08 | 553.59% |
| Q2 2024 Q2Q % growth | 0.01 112.50% | 0.01 | 0.00 | 17.69% |
| Q1 2024 Q2Q % growth | -0.03 83.33% | -0.14 | 0.11 | 78.48% |
| Q4 2023 Q2Q % growth | -0.19 -5.56% | -0.17 | -0.02 | -14.05% |
| Q3 2023 Q2Q % growth | -0.09 -50.00% | -0.17 | 0.08 | 47.21% |
| Q2 2023 Q2Q % growth | -0.08 68.00% | -0.19 | 0.11 | 57.22% |
| Q1 2023 Q2Q % growth | -0.18 33.33% | -0.23 | 0.05 | 20.30% |
| Q4 2022 Q2Q % growth | -0.18 28.00% | -0.28 | 0.10 | 35.33% |
| Q3 2022 Q2Q % growth | -0.06 84.62% | -0.17 | 0.11 | 65.10% |
| Q2 2022 Q2Q % growth | -0.25 32.43% | -0.23 | -0.02 | -9.75% |
| Q1 2022 Q2Q % growth | -0.27 32.50% | -0.27 | 0.00 | 0.91% |
| Q4 2021 Q2Q % growth | -0.25 -400.00% | -0.27 | 0.02 | 8.74% |
| Q3 2021 Q2Q % growth | -0.39 -39.29% | -0.34 | -0.05 | -14.87% |
| Q2 2021 Q2Q % growth | -0.37 -42.31% | -0.37 | 0.00 | 0.42% |
| Q1 2021 Q2Q % growth | -0.40 -166.67% | -0.37 | -0.03 | -7.44% |
| Q4 2020 Q2Q % growth | -0.05 93.59% | -0.25 | 0.20 | 79.93% |
| Q3 2020 Q2Q % growth | -0.28 -33.33% | -0.24 | -0.04 | -17.44% |
| Q2 2020 Q2Q % growth | -0.26 -52.94% | -0.24 | -0.02 | -10.29% |
| Q1 2020 Q2Q % growth | -0.15 -7.14% | -0.27 | 0.12 | 45.02% |
| Q4 2019 Q2Q % growth | -0.78 | -0.22 | -0.56 | -258.46% |
| Q3 2019 Q2Q % growth | -0.21 | -0.20 | -0.01 | -3.98% |
| Q2 2019 Q2Q % growth | -0.17 | -0.17 | 0.00 | 1.96% |
| Q1 2019 Q2Q % growth | -0.14 | -0.16 | 0.02 | 11.45% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 70.008M 22.41% | 64.971M | 5.037M | 7.75% |
| Q1 2025 Q2Q % growth | 62.465M 24.18% | 62.766M | -301K | -0.48% |
| Q4 2024 Q2Q % growth | 59.867M 32.76% | 61.143M | -1.276M | -2.09% |
| Q3 2024 Q2Q % growth | 67.771M 24.32% | 58.847M | 8.924M | 15.16% |
| Q2 2024 Q2Q % growth | 57.192M 37.83% | 56.156M | 1.036M | 1.84% |
| Q1 2024 Q2Q % growth | 50.303M 46.19% | 48.403M | 1.9M | 3.93% |
| Q4 2023 Q2Q % growth | 45.095M 58.56% | 45.214M | -119K | -0.26% |
| Q3 2023 Q2Q % growth | 54.515M -2.27% | 39.275M | 15.24M | 38.80% |
| Q2 2023 Q2Q % growth | 41.494M 47.19% | 38.91M | 2.584M | 6.64% |
| Q1 2023 Q2Q % growth | 34.409M 59.08% | 28.432M | 5.977M | 21.02% |
| Q4 2022 Q2Q % growth | 28.44M 21.54% | 28.335M | 105K | 0.37% |
| Q3 2022 Q2Q % growth | 55.78M 280.23% | 36.913M | 18.867M | 51.11% |
| Q2 2022 Q2Q % growth | 28.19M 325.83% | 27.685M | 505K | 1.82% |
| Q1 2022 Q2Q % growth | 21.63M 2,276.92% | 20.158M | 1.472M | 7.30% |
| Q4 2021 Q2Q % growth | 23.4M -53.23% | 22.435M | 965K | 4.30% |
| Q3 2021 Q2Q % growth | 14.67M 48,800.00% | 14.156M | 514K | 3.63% |
| Q2 2021 Q2Q % growth | 6.62M 21,966.67% | 4.786M | 1.834M | 38.32% |
| Q1 2021 Q2Q % growth | 910K 2,933.33% | 3.229M | -2.319M | -71.82% |
| Q4 2020 Q2Q % growth | 50.03M 166,666.67% | 30.6K | 49.999M | 163,396.73% |
| Q3 2020 Q2Q % growth | 30K -86.96% | 31.447K | -1.447K | -4.60% |
| Q2 2020 Q2Q % growth | 30K | 34.343K | -4.343K | -12.65% |
| Q1 2020 Q2Q % growth | 30K | 37.74K | -7.74K | -20.51% |
| Q4 2019 Q2Q % growth | 30K | 68.003K | -38.003K | -55.88% |
| Q3 2019 Q2Q % growth | 230K | 44.064K | 185.936K | 421.97% |
| Q2 2019 Q2Q % growth | 30K | 48.195K | -18.195K | -37.75% |
| Q1 2019 Q2Q % growth | 30K | 47.94K | -17.94K | -37.42% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.85% | 35.81% | 0% | 31.39% |
| Revenue | -0.86% | -0.55% | 0% | 0.25% |